AMGN vs PRK · P/E 24, rev $10.05B vs P/E 16, rev $400.4M
Amgen Inc (AMGN) versus Park National Corporation (PRK) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Park National Corporation (PRK) is a banks - regional company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported PRK revenue for 2026-06-30 was $400.4M. Net income was $100.4M. PRK currently screens at market cap $3.13B and trailing P/E 15.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. PRK currently screens at market cap $3.13B and trailing P/E 15.9.
Not investment advice. Open the AMGN and PRK stock pages for the full models.
Not investment advice.